Emerging viral and bacterial infections of the central nervous system

References

• Olival KJ, Daszak P. The ecology of emerging neurotropic viruses. J Neurovirol. 2005;11(5):441–446.
   PubMed Web of Science ®Google Scholar
• Tyler KL. Emerging viral infections of the central nervous system: part 1. Arch Neurol. 2009;66(8):939–948.
   Google Scholar
• Tyler KL. Emerging viral infections of the central nervous system: part 2. Arch Neurol. 2009;66(9):1065–1074.
   Google Scholar
• O’Sullivan JD, Allworth AM, Paterson DL, et al. Fatal encephalitis due to novel paramyxovirus transmitted from horses. Lancet. 1997; 349(9045):93–95.
   PubMed Web of Science ®Google Scholar
• Chua KB, Goh KJ, Wong KT, et al. Fatal encephalitis due to Nipah virus among pig-farmers in Malaysia. Lancet. 1999;354(9186):1257–1259.
   PubMed Web of Science ®Google Scholar
• Chua KB, Bellini WJ, Rota PA, et al. Nipah virus: a recently emergent deadly paramyxovirus. Science. 2000;288(5470):1432–1435.
   PubMed Web of Science ®Google Scholar
• Goh KJ, Tan CT, Chew NK, et al. Clinical features of Nipah virus encephalitis among pig farmers in Malaysia. N Engl J Med. 2000; 342(17):1229–1235.
   PubMed Web of Science ®Google Scholar
• Lee KE, Umapathi T, Tan CB, et al. The neurological manifestations of Nipah virus encephalitis, a novel paramyxovirus. Ann Neurol. 1999; 46(3):428–432.
   Web of Science ®Google Scholar
• Tan CT, Goh KJ, Wong KT, et al. Relapsed and late-onset Nipah encephalitis. Ann Neurol. 2002;51(6):703–708.
   PubMed Web of Science ®Google Scholar
• Wong KT, Shieh W, Kumar S, et al. Nipah virus infection: pathology and pathogenesis of an emerging paramyxoviral zoonosis. Am J Pathol. 2002;161(6):2153–2167.
   PubMed Web of Science ®Google Scholar
• Chadha MS, Comer JA, Lowe L, et al. Nipah virus-associated encephalitis outbreak, Siliguri, India. Emerg Infect Dis. 2006;12(2):235–240.
   PubMed Web of Science ®Google Scholar
• Gurley ES, Montgomery JM, Hossain MJ, et al. Person-to-person transmission of Nipah virus in a Bangladeshi community. Emerg Infect Dis. 2007;13(7):1031–1037.
   PubMed Web of Science ®Google Scholar
• Ishimaru Y, Nakano S, Yamaoka K, Takami S. Outbreaks of hand, foot, and mouth disease by enterovirus 71. High incidence of complication disorders of central nervous system. Arch Dis Child. 1980;55(8): 583–588.
   Web of Science ®Google Scholar
• Weng KF, Chen LL, Huang PN, Shih SR. Neural pathogenesis of enterovirus 71 infection. Microbes Infect. 2010;12(7):505–510.
   PubMed Web of Science ®Google Scholar
• Huang SW, Kiang D, Smith DJ, Wang JR. Evolution of re-emergent virus and its impact on enterovirus 71 epidemics. Exp Biol Med (Maywood). 2011;236(8):899–908.
   PubMed Web of Science ®Google Scholar
• Chan KP, Goh KT, Chong CY, Teo ES, Lau G, Ling AE. Epidemic hand, foot and mouth disease caused by human enterovirus 71, Singapore. Emerg Infect Dis. 2003;9(1):78–85.
   PubMed Web of Science ®Google Scholar
• Ooi MH, Wong SC, Podin Y, et al. Human enterovirus 71 disease in Sarawak, Malaysia: a prospective clinical, virological, and molecular epidemiological study. Clin Infect Dis. 2007;44(5):646–656.
   PubMed Web of Science ®Google Scholar
• Dauphin G, Zientara S, Zeller H, Murgue B. West Nile: worldwide current situation in animals and humans. Comp Immunol Microbiol Infect Dis. 2004;27(5):343–355.
   PubMed Web of Science ®Google Scholar
• Zeller HG, Schuffenecker I. West Nile virus: an overview of its spread in Europe and the Mediterranean basin in contrast to its spread in the Americas. Eur J Clin Microbiol Infect Dis. 2004;23(3):147–156.
   Web of Science ®Google Scholar
• Hayes EB, Komar N, Nasci RS, Montgomery SP, O’Leary DR, Campbell GL. Epidemiology and transmission dynamics of West Nile virus disease. Emerg Infect Dis. 2005;11(8):1167–1173.
   PubMed Web of Science ®Google Scholar
• Nash D, Mostashari F, Fine A, et al. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med. 2001; 344(24):1807–1814.
   PubMed Web of Science ®Google Scholar
• Rappole JH, Compton BW, Leimgruber P, Robertson J, King DI, Renner SC. Modeling movement of West Nile virus in the Western hemisphere. Vector Borne Zoonotic Dis. 2006;6(2):128–139.
   Web of Science ®Google Scholar
• Hayes EB, Sejvar JJ, Zaki SR, Lanciotti RS, Bode AV, Campbell GL. Virology, pathology, and clinical manifestations of West Nile virus disease. Emerg Infect Dis. 2005;11(8):1174–1179.
   PubMed Web of Science ®Google Scholar
• Murray KO, Baraniuk S, Resnick M, et al. Risk factors for encephalitis and death from West Nile virus infection. Epidemiol Infect. 2006; 134(6):1325–1332.
   Web of Science ®Google Scholar
• Sejvar JJ, Bode AV, Marfin AA, et al. West Nile virus-associated flaccid paralysis. Emerg Infect Dis. 2005;11(7):1021–1027.
   PubMed Web of Science ®Google Scholar
• Sejvar JJ, Haddad MB, Tierney BC, et al. Neurologic manifestations and outcome of West Nile virus infection. JAMA. 2003;290(4): 511–515.
   PubMed Web of Science ®Google Scholar
• Erlanger TE, Weiss S, Keiser J, Utzinger J, Wiedenmayer K. Past, present, and future of Japanese encephalitis. Emerg Infect Dis. 2009; 15(1):1–7.
   PubMed Web of Science ®Google Scholar
• Ghosh D, Basu A. Japanese encephalitis-a pathological and clinical perspective. PLoS Negl Trop Dis. 2009;3(9):e437.
   PubMed Web of Science ®Google Scholar
• Campbell GL, Hills SL, Fischer M, et al. Estimated global incidence of Japanese encephalitis: a systematic review. Bull World Health Organ. 2011;89(10):766–774, 774A–774E.
   PubMed Web of Science ®Google Scholar
• Solomon T. Control of Japanese encephalitis – within our grasp? N Engl J Med. 2006;355(9):869–871.
   PubMed Web of Science ®Google Scholar
• Pialoux G, Gaüzère B-, Jauréguiberry S, Strobel M. Chikungunya, an epidemic arbovirosis. Lancet Infect Dis. 2007;7(5):319–327.
   PubMed Web of Science ®Google Scholar
• Robin S, Ramful D, Le Seach’ F, Jaffar-Bandjee MC, Rigou G, Alessandri JL. Neurologic manifestations of pediatric chikungunya infection. J Child Neurol. 2008;23(9):1028–1035.
   Web of Science ®Google Scholar
• Ganesan K, Diwan A, Shankar SK, Desai SB, Sainani GS, Katrak SM. Chikungunya encephalomyeloradiculitis: report of 2 cases with neuroimaging and 1 case with autopsy findings. Am J Neuroradiol. 2008;29(9):1636–1637.
   Web of Science ®Google Scholar
• Singh SS, Manimunda SP, Sugunan AP, Sahina P, Vijayachari P. Four cases of acute flaccid paralysis associated with chikungunya virus infection. Epidemiol Infect. 2008;136(9):1277–1280.
   PubMed Web of Science ®Google Scholar
• Das T, Jaffar-Bandjee MC, Hoarau JJ, et al. Chikungunya fever: CNS infection and pathologies of a re-emerging arbovirus. Prog Neurobiol. 2010;91(2):121–129.
   PubMed Web of Science ®Google Scholar
• Couderc T, Chretien F, Schilte C, et al. A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease. PLoS Pathog. 2008;4(2):e29.
   PubMed Web of Science ®Google Scholar
• Nero C. Chikungunya, the traveling virus. Clin Microbiol Newsl. 2008; 30(13):97–100.
   Google Scholar
• Charrel RN, de Lamballerie X, Raoult D. Chikungunya outbreaks – the globalization of vectorborne diseases. New Engl J Med. 2007;356(8):769–771.
   Web of Science ®Google Scholar
• Schuffenecker I, Iteman I, Michault A, et al. Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak. PLoS Med. 2006;3(7):1058–1070.
   Web of Science ®Google Scholar
• Tsetsarkin KA, Vanlandingham DL, McGee CE, Higgs S. A single mutation in chikungunya virus affects vector specificity and epidemic potential. PLoS Pathog. 2007;3(12):e201.
   PubMed Web of Science ®Google Scholar
• Tsetsarkin KA, Weaver SC. Sequential adaptive mutations enhance efficient vector switching by chikungunya virus and its epidemic emergence. PLoS Pathog. 2011;7(12):e1002412.
   PubMed Web of Science ®Google Scholar
• Eccles R. Understanding the symptoms of the common cold and influenza. Lancet Infect Dis. 2005;5(11):718–725.
   PubMed Web of Science ®Google Scholar
• Writing Committee of the Second World Health Organization Consultation on Clinical Aspects of Human Infection with Avian Influenza A (H5N1) Virus, Abdel-Ghafar AN, Chotpitayasunondh T, et al. Update on avian influenza A (H5N1) virus infection in humans. N Engl J Med. 2008;358(3):261–273.
   PubMed Web of Science ®Google Scholar
• Farooq O, Faden HS, Cohen ME, et al. Neurologic complications of 2009 influenza-A H1 N1 infection in children. J Child Neurol. 2011. Epub October 12, 2011.
   Web of Science ®Google Scholar
• Susser ES, Schaefer CA, Brown AS, Begg MD, Wyatt RJ. The design of the prenatal determinants of schizophrenia study. Schizophr Bull. 2000;26(2):257–273.
   Web of Science ®Google Scholar
• Brown AS, Begg MD, Gravenstein S, et al. Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch Gen Psychiatry. 2004;61(8):774–780.
   PubMed Web of Science ®Google Scholar
• Fatemi SH, Emamian ES, Kist D, et al. Defective corticogenesis and reduction in Reelin immunoreactivity in cortex and hippocampus of prenatally infected neonatal mice. Mol Psychiatry. 1999;4(2):145–154.
   Web of Science ®Google Scholar
• Shi L, Fatemi SH, Sidwell RW, Patterson PH. Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J Neurosci. 2003;23(1):297–302.
   PubMed Web of Science ®Google Scholar
• Niu S, Renfro A, Quattrocchi CC, Sheldon M, D’Arcangelo G. Reelin promotes hippocampal dendrite development through the VLDLR/ ApoER2-Dab1 pathway. Neuron. 2004;41(1):71–84.
   PubMed Web of Science ®Google Scholar
• Davis LE. Neurologic and muscular complications of the 2009 influenzaA (H1N1) pandemic. Curr Neurol Neurosci Rep. 2010;10(6):476–483.
   Web of Science ®Google Scholar
• Hsu J, Santesso N, Mustafa R, et al. Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies. Ann Intern Med. 2012. Epub February 27, 2012.
   Web of Science ®Google Scholar
• Engsig FN, Hansen A-E, Omland LH, et al. Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study. J Infect Dis. 2009;199(1):77–83.
   PubMed Web of Science ®Google Scholar
• Calabrese LH, Molloy ES, Huang D, Ransohoff RM. Progressive multifocal leukoencephalopathy in rheumatic diseases: evolving clinical and pathologic patterns of disease. Arthritis Rheum. 2007;56(7):2116–2128.
   PubMed Web of Science ®Google Scholar
• Van Assche G, Van Ranst M, Sciot R, et al. Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn’s disease. N Engl J Med. 2005;353(4):362–368.
   PubMed Web of Science ®Google Scholar
• Stüve O, Marra CM, Jerome KR, et al. Immune surveillance in multiple sclerosis patients treated with natalizumab. Ann Neurol. 2006;59(5): 743–747.
   PubMed Web of Science ®Google Scholar
• Berger JR. Progressive multifocal leukoencephalopathy. Curr Neurol Neurosci Rep. 2007;7(6):461–469.
   Web of Science ®Google Scholar
• Dewhurst S, McIntyre K, Schnabel K, Hall CB. Human herpesvirus 6 (HHV-6) variant B accounts for the majority of symptomatic primary HHV-6 infections in a population of US infants. J Clin Microbiol. 1993;31(2):416–418.
   Web of Science ®Google Scholar
• Yamanishi K, Okuno T, Shiraki K, et al. Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet. 1988; 1(8594):1065–1067.
   Web of Science ®Google Scholar
• Yoshikawa T, Nakashima T, Suga S, et al. Human herpesvirus-6 DNA in cerebrospinal fluid of a child with exanthem subitum and meningoencephalitis. Pediatrics. 1992;89(5 Pt 1):888–890.
   Web of Science ®Google Scholar
• Hall CB, Long CE, Schnabel KC, et al. Human herpesvirus-6 infection in children. A prospective study of complications and reactivation. N Engl J Med. 1994;331(7):432–438.
   PubMed Web of Science ®Google Scholar
• Seeley WW, Marty FM, Holmes TM, et al. Post-transplant acute limbic encephalitis: clinical features and relationship to HHV6. Neurology. 2007;69(2):156–165.
   PubMed Web of Science ®Google Scholar
• Donati D, Akhyani N, Fogdell-Hahn A, et al. Detection of human herpesvirus-6 in mesial temporal lobe epilepsy surgical brain resections. Neurology. 2003;61(10):1405–1411.
   Web of Science ®Google Scholar
• Fotheringham J, Donati D, Akhyani N, et al. Association of human herpesvirus-6B with mesial temporal lobe epilepsy. PLoS Med. 2007; 4(5):e180.
   PubMed Web of Science ®Google Scholar
• Goodman AD, Mock DJ, Powers JM, Baker JV, Blumberg BM. Human herpesvirus 6 genome and antigen in acute multiple sclerosis lesions. J Infect Dis. 2003;187(9):1365–1376.
   Web of Science ®Google Scholar
• Chan PKS, Ng HK, Hui M, Ip M, Cheung JLK, Cheng AF. Presence of human herpesviruses 6, 7, and 8 DNA sequences in normal brain tissue. J Med Virol. 1999;59(4):491–495.
   Web of Science ®Google Scholar
• Vezzani A, Granata T. Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia. 2005;46(11):1724–1743.
   PubMed Web of Science ®Google Scholar
• Olli-Lahdesmaki T, Haataja L, Parkkola R, Waris M, Bleyzac N, Ruuskanen O. High-dose ganciclovir in HHV-6 encephalitis of an immunocompetent child. Pediatr Neurol. 2010;43(1):53–56.
   Web of Science ®Google Scholar
• Whitley RJ. Herpes simplex encephalitis: adolescents and adults. Antiviral Res. 2006;71(2–3):141–148.
   PubMed Web of Science ®Google Scholar
• Jamieson GA, Maitland NJ, Craske J, Wilcock GK, Itzhaki RF. Detection of herpes simplex virus type 1 DNA sequences in normal and Alzheimer’s disease brain using polymerase chain reaction. Biochem Soc Trans. 1991;19(2):122S.
   PubMed Web of Science ®Google Scholar
• Wozniak MA, Mee AP, Itzhaki RF. Herpes simplex virus type 1 DNA is located within Alzheimer’s disease amyloid plaques. J Pathol. 2009; 217(1):131–138.
   PubMed Web of Science ®Google Scholar
• Wozniak MA, Shipley SJ, Combrinck M, Wilcock GK, Itzhaki RF. Productive herpes simplex virus in brain of elderly normal subjects and Alzheimer’s disease patients. J Med Virol. 2005;75(2):300–306.
   PubMed Web of Science ®Google Scholar
• Letenneur L, Pérès K, Fleury H, et al. Seropositivity to herpes simplex virus antibodies and risk of Alzheimer’s disease: a population-based cohort study. PLoS One. 2008;3(11):e3637.
   PubMed Web of Science ®Google Scholar
• Itzhaki RF, Lin WR, Shang D, Wilcock GK, Faragher B, Jamieson GA. Herpes simplex virus type 1 in brain and risk of Alzheimer’s disease [see comments]. Lancet. 1997;349(9047):241–244.
   PubMed Web of Science ®Google Scholar
• Cheng SB, Ferland P, Webster P, Bearer EL. Herpes simplex virus dances with amyloid precursor protein while exiting the cell. PLoS One. 2011;6(3):e17966.
   Web of Science ®Google Scholar
• Wozniak MA, Frost AL, Itzhaki RF. Alzheimer’s disease-specific tau phosphorylation is induced by herpes simplex virus type 1. J Alzheimers Dis. 2009;16(2):341–350.
   PubMed Web of Science ®Google Scholar
• Benetti L, Roizman B. Herpes simplex virus protein kinase Us3 activates and functionally overlaps protein kinase A to block apoptosis. Proc Natl Acad Sci U S A. 2004;101(25):9411–9416.
   PubMed Web of Science ®Google Scholar
• Santana S, Recuero M, Bullido MJ, Valdivieso F, Aldudo J. Herpes simplex virus type I induces the accumulation of intracellular betaamyloid in autophagic compartments and the inhibition of the nonamyloidogenic pathway in human neuroblastoma cells. Neurobiol Aging. 2012;33(2):430.e19–e33. Epub January 26, 2011.
   PubMed Web of Science ®Google Scholar
• Wozniak MA, Frost AL, Preston CM, Itzhaki RF. Antivirals reduce the formation of key alzheimer’s disease molecules in cell cultures acutely infected with herpes simplex virus type 1. PLoS One. 2011; 6(10):e25152.
   PubMed Web of Science ®Google Scholar
• McGavern DB, Kang SS. Illuminating viral infections in the nervous system. Nat Rev Immunol. 2011;11(5):318–329.
   PubMed Web of Science ®Google Scholar
• Drevets DA, Leenen PJ, Greenfield RA. Invasion of the central nervous system by intracellular bacteria. Clin Microbiol Rev. 2004;17(2): 323–347.
   PubMed Web of Science ®Google Scholar
• Henry CS, Overbeek R, Xia F, et al. Connecting genotype to phenotype in the era of high-throughput sequencing. Biochim Biophys Acta. 2011; 1810(10):967–977.
   Web of Science ®Google Scholar
• Watt G, Parola P. Scrub typhus and tropical rickettsioses. Curr Opin Infect Dis. 2003;16(5):429–436.
   Web of Science ®Google Scholar
• Kelly DJ, Fuerst PA, Ching WM, Richards AL. Scrub typhus: The geographic distribution of phenotypic and genotypic variants of Orientia tsutsugamushi. Clin Infect Dis. 2009;48(Suppl 3):S203–S230.
   PubMedGoogle Scholar
• Kim DE, Lee SH, Park KI, Chang KH, Roh JK. Scrub typhus encephalomyelitis with prominent focal neurologic signs. Arch Neurol. 2000; 57(12):1770–1772.
   Google Scholar
• Mahajan SK, Rolain J, Kanga A, Raoult D. Scrub typhus involving central nervous system, India, 2004–2006. Emerg Infect Dis. 2010;16(10): 1641–1643.
   Web of Science ®Google Scholar
• Rajapakse S, Rodrigo C, Fernando SD. Drug treatment of scrub typhus. Trop Doct. 2011;41(1):1–4.
   PubMed Web of Science ®Google Scholar
• Olano JP, Hogrefe W, Seaton B, Walker DH. Clinical manifestations, epidemiology, and laboratory diagnosis of human monocytotropic ehrlichiosis in a commercial laboratory setting. Clin Diagn Lab Immunol. 2003;10(5):891–896.
   Google Scholar
• Demma LJ, Holman RC, McQuiston JH, Krebs JW, Swerdlow DL. Human monocytic ehrlichiosis and human granulocytic anaplasmosis in the United States, 2001–2002. Ann NY Acad Sci. 2006;1078: 118–119.
   Web of Science ®Google Scholar
• Olano JP, Masters E, Hogrefe W, Walker DH. Human monocytotropic ehrlichiosis, Missouri. Emerg Infect Dis. 2003;9(12):1579–1586.
   Web of Science ®Google Scholar
• Marshall GS, Jacobs RF, Schutze GE, et al. Ehrlichia chaffeensis seroprevalence among children in the southeast and south-central regions of the United States. Arch Pediatr Adolesc Med. 2002;156(2):166–170.
   Google Scholar
• Anderson BE, Sims KG, Olson JG, et al. Amblyomma americanum: a potential vector of human ehrlichiosis. Am J Trop Med Hyg. 1993; 49(2):239–244.
   PubMed Web of Science ®Google Scholar
• Ratnasamy N, Everett ED, Roland WE, McDonald G, Caldwell CW. Central nervous system manifestations of human ehrlichiosis. Clin Infect Dis. 1996;23(2):314–319.
   Web of Science ®Google Scholar
• Rikihisa Y. Ehrlichia subversion of host innate responses. Curr Opin Microbiol. 2006;9(1):95–101.
   Web of Science ®Google Scholar
• Dierberg KL, Dumler JS. Lymph node hemophagocytosis in rickettsial diseases: a pathogenetic role for CD8 T lymphocytes in human monocytic ehrlichiosis (HME)? BMC Infect Dis. 2006;6:121.
   Web of Science ®Google Scholar
• Ismail N, Bloch KC, McBride JW. Human ehrlichiosis and anaplasmosis. Clin Lab Med. 2010;30(1):261–292.
   Web of Science ®Google Scholar
• Thomas RJ, Dumler JS, Carlyon JA. Current management of human granulocytic anaplasmosis, human monocytic ehrlichiosis and Ehrlichia ewingii ehrlichiosis. Expert Rev Anti Infect Ther. 2009;7(6): 709–722.
   PubMed Web of Science ®Google Scholar
• Grayston JT, Campbell LA, Kuo CC, et al. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis. 1990;161: 618–625.
   PubMed Web of Science ®Google Scholar
• Moazed TC, Kuo CC, Grayston JT, Campbell LA. Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse. J Infect Dis. 1998;177(5):1322–1325.
   Web of Science ®Google Scholar
• Balin BJ, Gerard HC, Arking EJ, et al. Identification and localization of Chlamydia pneumoniae in the Alzheimer’s brain. Med Microbiol Immunol (Berl). 1998;187(1):23–42.
   PubMed Web of Science ®Google Scholar
• Sriram S, Mitchell W, Stratton C. Multiple sclerosis associated with Chlamydia pneumoniae infection of the CNS. Neurology. 1998;50(298145402):571–572.
   Google Scholar
• Balin BJ, Little CS, Hammond CJ, et al. Chlamydophila pneumoniae and the etiology of late-onset Alzheimer’s disease. J Alzheimers Dis. 2008;13(4):371–380.
   PubMed Web of Science ®Google Scholar
• Contini C, Seraceni S, Cultrera R, Castellazzi M, Granieri E, Fainardi E. Chlamydophila pneumoniae infection and its role in neurological disorders. Interdiscip Perspect Infect Dis. 2010;2010:273573. Epub February 21, 2010.
   PubMedGoogle Scholar
• Little CS, Hammond CJ, MacIntyre A, Balin BJ, Appelt DM. Chlamydia pneumoniae induces Alzheimer-like amyloid plaques in brains of BALB/c mice. Neurobiol Aging. 2004;25(4):419–429.
   PubMed Web of Science ®Google Scholar
• Little CS, Bowe A, Lin R, et al. Age alterations in extent and severity of experimental intranasal infection with Chlamydophila pneumoniae in BALB/c mice. Infect Immun. 2005;73(3):1723–1734.
   Web of Science ®Google Scholar
• Boelen E, Steinbusch HW, Bruggeman CA, Stassen FR. The inflammatory aspects of Chlamydia pneumoniae-induced brain infection. Drugs Today (Barc). 2009;45(Suppl B):159–164.
   Google Scholar
• Appelt DM, Roupas MR, Way DS, et al. Inhibition of apoptosis in neuronal cells infected with Chlamydophila (Chlamydia) pneumoniae. BMC Neurosci. 2008;9:13.
   Web of Science ®Google Scholar
• Thiem U, Heppner HJ, Pientka L. Elderly patients with community-acquired pneumonia: optimal treatment strategies. Drugs Aging. 2011; 28(7):519–537.
   Web of Science ®Google Scholar
• Loeb MB, Molloy DW, Smieja M, et al. A randomized, controlled trial of doxycycline and rifampin for patients with Alzheimer’s disease. J Am Geriatr Soc. 2004;52(3):381–387.
   PubMed Web of Science ®Google Scholar
• Rupprecht TA, Koedel U, Fingerle V, Pfister HW. The pathogenesis of lyme neuroborreliosis: from infection to inflammation. Mol Med. 2008;14(3–4):205–212.
   PubMed Web of Science ®Google Scholar
• MacDonald AB, Miranda JM. Concurrent neocortical borreliosis and Alzheimer’s disease. Hum Pathol. 1987;18(7):759–761.
   PubMed Web of Science ®Google Scholar
• Miklossy J. Alzheimer’s disease – a spirochetosis? Neuroreport. 1993; 4(7):841–848.
   Google Scholar
• Miklossy J, Kis A, Radenovic A, et al. Beta-amyloid deposition and Alzheimer’s type changes induced by Borrelia spirochetes. Neurobiol Aging. 2006;27(2):228–236.
   PubMed Web of Science ®Google Scholar
• O’Connell S. Lyme borreliosis: current issues in diagnosis and management. Curr Opin Infect Dis. 2010;23(3):231–235.
   Web of Science ®Google Scholar
• Cover TL, Blaser MJ. Helicobacter pylori in health and disease. Gastroenterology. 2009;136(6):1863–1873.
   PubMed Web of Science ®Google Scholar
• Dobbs SM, Dobbs RJ, Weller C, Charlett A. Link between Helicobacter pylori infection and idiopathic parkinsonism. Med Hypotheses. 2000;55(2):93–98.
   PubMed Web of Science ®Google Scholar
• Charlett A, Dobbs RJ, Dobbs SM, Weller C, Brady P, Peterson DW. Parkinsonism: siblings share Helicobacter pylori seropositivity and facets of syndrome. Acta Neurol Scand. 1999;99(1):26–35.
   PubMed Web of Science ®Google Scholar
• Weller C, Charlett A, Oxlade NL, et al. Role of chronic infection and inflammation in the gastrointestinal tract in the etiology and pathogenesis of idiopathic parkinsonism. Part 3: predicted probability and gradients of severity of idiopathic parkinsonism based on H. pylori antibody profile. Helicobacter. 2005;10(4):288–297.
   Web of Science ®Google Scholar
• Nielsen HH, Qiu J, Friis S, Wermuth L, Ritz B. Treatment for Helicobacter pylori infection and risk of Parkinson’s disease in Denmark. Eur J Neurol. 2012. Epub January 17, 2012.
   Web of Science ®Google Scholar
• Gerhard M, Rad R, Prinz C, Naumann M. Pathogenesis of Helicobacter pylori infection. Helicobacter. 2002;7(Suppl 1):17–23.
   PubMedGoogle Scholar
• Lundgren A, Suri-Payer E, Enarsson K, Svennerholm AM, Lundin BS. Helicobacter pylori-specific CD4+ CD25high regulatory T cells suppress memory T-cell responses to H. pylori in infected individuals. Infect Immun. 2003;71(4):1755–1762.
   PubMed Web of Science ®Google Scholar
• Gasbarrini A, Carloni E, Gasbarrini G, Chisholm SA. Helicobacter pylori and extragastric diseases – other Helicobacters. Helicobacter. 2004;9(Suppl 1):57–66.
   Google Scholar
• Chuah SK, Tsay FW, Hsu PI, Wu DC. A new look at anti-Helicobacter pylori therapy. World J Gastroenterol. 2011;17(35):3971–3975.
   PubMed Web of Science ®Google Scholar